CORE
🇺🇦Â
 make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Phase 2 Study of Monotherapy Galunisertib (LY2157299 Monohydrate) in Very Low-, Low-, and Intermediate-Risk Patients with Myelodysplastic Syndromes
Author
Alan F. List
Alan Y Chiang
+15Â more
Amit Verma
Ann L Cleverly
Aristoteles Giagounidis
David Valcarcel
Durisala Desiaih
Gianluca Gaidano
Jaime Perez de Oteyza
Jan Janssen
MarÃa DÃez-Campelo
Michael Lahn
Rami S. Komrokji
Richard F. Schlenk
Susan C. Guba
Uwe Platzbecker
Valeria Santini
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref